Can YKL-40 be an Inflammatory Biomarker in Vitamin D Deficiency?

Abstract. Vitamin D deficiency is associated with several non-homeostatic conditions and/or diseases like inflammation, atherosclerosis, cardiovascular disease and mortality. YKL-40 is a glycoprotein, secreted by macrophages, neutrophils and different cell types and it is also associated with inflammation and pathological tissue remodeling. In this study, we aimed to evaluate relationship between the proinflammatory biomarkers YKL-40 and hs-CRP levels and vitamin D deficiency. Our study group includes 45 subjects with vitamin D deficiency (Group 1) (20 M, 25 F; mean age 37.72 ± 7.70 years) and 40 age and sex-matched healthy subjects with normal serum levels of vitamin D (Group 2) (19 M, 21 F; mean age 39.26 ± 7.41 years). Plasma 25 (OH) vitamin D levels were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Plasma YKL-40 analysis was performed by ELISA. Serum hs-CRP levels were measured by nephelometric method. Plasma vitamin D levels below 20 ng/mL were accepted as vitamin D deficiency. Although we could not find any significant differences by means of serum hs-CRP levels between Group 1 and Group 2 (2.21 (0.27–11.70); 1.79 (0.16–9.85) mg/L, p = 0.247), plasma YKL-40 levels were significantly higher in group 1 than group2 (70.47 (17.84–198.50); 47.14 (4.80–135.48) ng/mL, p = 0.047). In literature, vitamin D deficiency is associated with inflammation. In our study, we found similar hs-CRP levels between groups and higher YKL-40 levels in group 1. Vitamin D deficiency may be related to high YKL-40 levels in terms of causing chronic inflammation.

Download Full-text

Abstract 526: Serum Levels of 25 Hidroxyvitamin D and Its Association With Body Fat, Metabolic Profile, Inflammatory Biomarkers, Blood Pressure and Endothelial Function

Hypertension ◽

10.1161/hyp.62.suppl_1.a526 ◽

2013 ◽

Vol 62 (suppl_1) ◽

Author(s):

Thaís d Ferreira ◽

Márcia R Torres ◽

Débora C Valença ◽

Maria d Rodrigues ◽

José F Neto ◽

...

Keyword(s):

Vitamin D ◽

Endothelial Function ◽

Vitamin D Deficiency ◽

Metabolic Profile ◽

Serum Levels ◽

Inflammatory Biomarkers ◽

Body Adiposity ◽

Group 2 ◽

Deficiency Group ◽

Group 1

Background: Recent evidence suggests that vitamin D deficiency is associated with an increased risk of cardiovascular morbidity and mortality. However, the relationship between vitamin D deficiency and cardiovascular disease risk factors has not been established. Objectives: To investigate the prevalence of vitamin D deficiency and its association with body adiposity, metabolic profile, inflammatory biomarkers, blood pressure (BP) and endothelial function in healthy premenopausal women. Methods: In this cross-sectional study were included 73 adult women who were submitted to the evaluation of: serum levels of 25 hidroxyvitamin D [25(OH)D]; body adiposity; metabolic profile (glucose, insulin, HOMA-IR, leptin, triglycerides and cholesterol); inflammatory biomarkers (adiponectin and C-reactive protein); BP; and endothelial function by serum concentrations of adhesion molecules and by reactive hyperemia index (RHI), determined by peripheral arterial tonometry, using Endo-PAT 2000®. Participants were stratified into 2 groups according to their vitamin D status: with vitamin D deficiency (Group 1; 25 (OH) D < 20ng/ml; n=12), and without vitamin D deficiency (Group 2; 25 (OH) D ≥ 20ng/ml; n=61). Results: The prevalence of vitamin D deficiency was 16% (12 of 73). Women in Group 1 compared with those in Group 2 were older (36.5±3.2 vs. 30.4±1.1 years; p=0.03) and showed higher values of BMI (28.7±1.4 vs. 25.1±0.7kg/m2; p=0.03); % body fat (35.3±1.7 vs. 31.1±0.7%; p=0.02); glucose (88.3±3.2 vs. 80.2±1.1 mg/dl; p=0.01); HOMA-IR (6.3±0.7 vs. 4.4±0.2; p=0.002); and leptin (29.6±3.5 vs. 20.9±1.7 ng/ml; p=0.04). RHI was lower in participants in Group 1 than in Group 2 (1.7±0.1 vs. 2.1±0.1; p=0.02). After adjustments for age and BMI, women with vitamin D deficiency remained with higher levels of glucose and HOMA-IR, and lower levels of RHI. Systolic and diastolic BP were higher in Group 1 than in Group 2 (110.2 ± 5.1 vs. 102.9 ± 1.4mmHg and 72.8 ± 4,0 vs. 68.6 ± 1.3mmHg, respectively), however without statistical significance. The other variables did not differ between groups. Conclusions: In the present study, vitamin D deficiency was associated with higher body adiposity, greater insulin resistance and worse endothelial function in women.

Download Full-text

Evaluation of Vitamin D Levels and Response to Therapy of Childhood Migraine

Medicina ◽

10.3390/medicina55070321 ◽

2019 ◽

Vol 55 (7) ◽

pp. 321 ◽

Cited By ~ 3

Author(s):

Kılıç ◽

Kılıç

Keyword(s):

Vitamin D ◽

Vitamin D Deficiency ◽

Response To Therapy ◽

Pediatric Migraine ◽

Migraine Frequency ◽

Vitamin D Levels ◽

Baseline Values ◽

Group 2 ◽

25 Oh Vitamin D ◽

Group 1

Background and Objectives: Vitamin D deficiency and insufficiency are related with many neurological diseases such as migraine. The aim of this study was to investigate whether pediatric migraine is associated with vitamin D deficiency and the effect of vitamin D therapy on the frequency, duration, severity of migraine attacks, and Pediatric Migraine Disability Assessment (PedMIDAS). Materials and Methods: We retrospectively examined the patients’ levels of calcium, phosphorus, parathyroid hormone, alkaline phosphatase, and 25-OH vitamin D of 92 pediatric migraine patients. The patients were divided into two groups: Group 1, which had low vitamin D levels and received vitamin D therapy, and group 2, which had normal vitamin D levels and did not receive vitamin D therapy. Migraine severity measured by the visual analog scale (VAS), migraine frequency, and duration as well as scores on the PedMIDAS questionnaire were compared with regard to the 25-OH vitamin D levels. In addition, pre- and posttreatment pedMIDAS scores, VAS, migraine frequency, and duration were compared with baseline values. Results: A total of 34.7% patients had vitamin D insufficiency (vitamin D levels between 10 and 20 ng/mL), whereas 10.8% had vitamin D deficiency (vitamin D levels < 10 ng/mL). Migraine frequency, migraine duration, and PedMIDAS scores were significantly higher in the group 1 than group 2 (p = 0.004, p = 0.008, and p = 0.001). After vitamin D therapy at sixth months of supplementation, migraine duration was reported statistically significant shorter (p < 0.001) and the migraine frequency, VAS scores, and pedMIDAS scores were statistically significant lower compared with baseline values in group 1 (p < 0.001). Conclusion: We found a marked correlation between pediatric migraine and vitamin D levels. Vitamin D therapy was beneficial in migraine pediatric patients.

Download Full-text

Whether Adding Vitamin D to Tadalafil 5 mg Treatment Is Useful in Patients with Erectile Dysfunction and Vitamin D Deficiency?

Urologia Internationalis ◽

10.1159/000514056 ◽

2021 ◽

pp. 1-6

Author(s):

Aykut Demirci ◽

Murat Çakan ◽

Murat Topçuoğlu

Keyword(s):

Vitamin D ◽

Erectile Dysfunction ◽

Vitamin D Deficiency ◽

Sexual Desire ◽

Erectile Function ◽

Phosphodiesterase Type 5 Inhibitors ◽

Vitamin D Levels ◽

Group 2 ◽

Phosphodiesterase Type ◽

Group 1

Introduction: Numerous factors such as endothelial disease and hormonal disorder cause the development of erectile dysfunction (ED). However, the relationship between vitamin D deficiency (VDD) and ED is unclear. Moreover, the benefit of vitamin D replacement on ED patients with VDD is uncertain. As far as we know, there is no study yet in the literature regarding the addition of vitamin D to phosphodiesterase type 5 inhibitors in the treatment of ED patients with VDD. In this study, we investigated whether adding vitamin D to daily tadalafil treatment would be beneficial in ED patients with VDD. Methods: A total of 111 patients with VDD accompanying ED were retrospectively evaluated between January 2016 and December 2019. Patients were divided into 2 groups according to the treatment they received. Group 1 (n = 58) was treated with daily oral tadalafil 5 mg, while group 2 (n = 53) received oral tadalafil 5 mg and 4,000 IU vitamin D3. Total International Index of Erectile Function-15 (IIEF-15) scores and vitamin D levels of the groups were compared at the end of the study. Results: The mean vitamin D level was increased statistically significant in group 2, but no difference was seen in group 1 (p < 0.001 and p > 0.05, respectively). There was a significant increase in median erectile function, orgasmic function, sexual desire, sexual satisfaction, and overall satisfaction scores in both groups (p < 0.001). However, the increase in median erectile function and sexual desire scores was significantly higher in group 2 compared to group 1 at the end of the study (p = 0.01 and p < 0.001, respectively). Conclusion: We found that adding vitamin D to 5 mg oral daily tadalafil treatment may have an additional positive effect on erectile function and sexual desire in ED patients with VDD.

Download Full-text

Vitamin D deficiency as a risk factor for COVID-19 infection in children

International Journal of Contemporary Pediatrics ◽

10.18203/2349-3291.ijcp20212474 ◽

2021 ◽

Vol 8 (7) ◽

pp. 1209

Author(s):

Adarsh E. ◽

Malavika Jayanna ◽

Neethu N. Reddy

Keyword(s):

Vitamin D ◽

Risk Factor ◽

Vitamin D Deficiency ◽

Clinical Findings ◽

Immunological Mechanism ◽

Laboratory Parameters ◽

Vitamin D Levels ◽

Significant Difference ◽

Group 2 ◽

Group 1

Background: Vitamin D deficiency is a major public health problem in all age groups. Through its immunomodulatory, anti-inflammatory and antioxidant effects it is shown to have a protective effect in COVID affected children. The objective of the study was to evaluate vitamin D deficiency as a risk factor for developing COVID-19 infection in children and to study the relationship between vitamin D deficiency and the clinical findings in COVID-19 positive children.Methods: A retrospective study of all COVID positive children aged 1 month to 15 years admitted to COVID Paediatric ward of Rajarajeshwari Medical hospital from July 2020-November 2020. All COVID positive children confirmed with RTPCR of age group 1 month to 15 years will be included in the study the age at admission, clinical and laboratory data, and 25‐hydroxycholecalciferol (25‐OHD) levels will be recorded. Patients diagnosed with COVID 19 are divided into 2 groups those with deficient and insufficient vitamin D levels were determined as group 1 and patients with normal vitamin D levels as Group 2. Those with vitamin D Levels below 20ng/ml were determined as group 1 and those with >20 ng/ml as group 2. The various clinical outcomes and laboratory parameters were compared between the two groups.Results: Patients with COVID 19 had significantly lower vitamin D levels 22.39±6.27 (p≤0.0001). Patients in group A that is vitamin D deficient and insufficient group had higher levels of ferritin (p≤0.0001).No significant difference was found between other clinical and laboratory parameters between group 1 and group 2.Conclusions: This is one of the first to evaluate vitamin D levels and its relationship with clinical findings in paediatric patients with covid-19. Although vitamin D does not play a role in the pathogenesis of COVID-19 we do believe its putative role in preventing and treating the disease The results suggest that vitamin D levels may be associated with the occurrence and management of the COVID-19 disease by modulating the immunological mechanism to the virus in paediatric population.

Download Full-text

Vitamin D among Patients of Pulmonary and Extrapulmonary Tuberculosis: A Prospective Case-control Study

Current Respiratory Medicine Reviews ◽

10.2174/1573398x16999200626160349 ◽

2020 ◽

Vol 16 (1) ◽

pp. 59-65

Author(s):

Doaa Gadallah ◽

Ahmed Sedky ◽

Hend Mohamed Esmaeel

Keyword(s):

Vitamin D ◽

Vitamin D Deficiency ◽

Extrapulmonary Tuberculosis ◽

Serum Levels ◽

Case Control ◽

Normal Serum ◽

Control Group ◽

Tb Treatment ◽

Vitamin D Levels ◽

Control Study

Background: Vitamin D has an essential role in enhancing the immune system to fight and destroy bacteria. People with vitamin D deficiency are highly liable to develop active pulmonary and extrapulmonary tuberculosis. Objective: : To evaluate the serum level of vitamin D among patients with pulmonary and extrapulmonary tuberculosis. Patients and Methods: A case-control prospective study was conducted among patients with pulmonary and extrapulmonary tuberculosis and asymptomatic persons (controls). The study included 80 participants, 50 were TB patients, while 30 were controls. Vitamin D 1, 25(OH) assay was done for all. Results: Vitamin D assay of the included subjects revealed that 52 patients were vitamin D deficient, 7 patients had insufficient vitamin D and 21 had normal serum levels. Of the extrapulmonary TB patients, 35 (100%) had vitamin D deficiency, in pulmonary TB patients, 15 (100%) were vitamin D deficient. While 2 study subjects (6.7%) in the control group were deficient of vitamin D, 7 (23.3%) had insufficient vitamin D and 21cases had normal vitamin D levels. There was a statistically significant relationship between pulmonary and extrapulmonary TB cases and vitamin D deficiency (P< 0.001). Conclusion: Vitamin D deficiency was found among pulmonary and extrapulmonary tuberculosis patients especially among female patients and patients in rural residence. The current study needs additional work to evaluate the value of adding vitamin D to the TB treatment regimen.

Download Full-text

The Impact of COVID-19 Pandemic during 2020–2021 on the Vitamin D Serum Levels in the Paediatric Population in Warsaw, Poland

Nutrients ◽

10.3390/nu13061990 ◽

2021 ◽

Vol 13 (6) ◽

pp. 1990

Author(s):

Agnieszka Rustecka ◽

Justyna Maret ◽

Ada Drab ◽

Michalina Leszczyńska ◽

Agata Tomaszewska ◽

...

Keyword(s):

Vitamin D ◽

Seasonal Variability ◽

Serum Levels ◽

Paediatric Population ◽

Sunlight Exposure ◽

Vitamin D Levels ◽

The Mean ◽

Group 2 ◽

The Impact ◽

Group 1

Background: The main source of vitamin D is skin synthesis, which depends on sunlight exposure. During the pandemic, COVID-19 children were obliged to home confinement, which potentially limiting sunlight exposure. The aim of this study was to evaluate whether home confinement led to decreased vitamin D serum levels in children in Warsaw, Poland. Methods: The study included 1472 children who were divided into two groups, based on the date of 25(OH)D level blood sampling: before and during the pandemic. Children under 1 year of age (infants) were analysed separately. Results: A statistically significant decrease in the average level of vitamin D was observed between groups of children over 1 year of age (35 ng/mL ± 18 vs. 31 ng/mL ± 14). In infants from both groups, the mean vitamin D levels were within the normal range (Group 1 inf 54 ng/mL ± 21 vs. Group 2 inf 47 ng/mL ± 15). The characteristic seasonal variability was observed before the pandemic, with maximal vitamin D levels in summer (40 ng/mL ± 17) and minimal levels in winter (30 ng/mL ± 14). During the pandemic, no seasonal variability was observed (summer 30 ng/mL ± 11 vs. winter 30 ng/mL ± 19). Conclusions: The COVID-19 pandemic restrictions led to a significant decrease in vitamin D serum levels in children.

Download Full-text

Effect of vitamin D supplementation on growth parameters of children with vitamin D deficiency: a community based randomized controlled trial

International Journal of Contemporary Pediatrics ◽

10.18203/2349-3291.ijcp20174733 ◽

2017 ◽

Vol 4 (6) ◽

pp. 2070

Author(s):

Sagul R. Mugunthan ◽

Yashwant K. Rao ◽

Tanu Midha ◽

Anurag Bajpai

Keyword(s):

Vitamin D ◽

Alkaline Phosphatase ◽

Vitamin D Deficiency ◽

Growth Parameters ◽

Controlled Trial ◽

Vitamin D Supplementation ◽

Community Based ◽

Randomized Controlled ◽

Group 2 ◽

Group 1

Background: Vitamin D deficiency remains the most common cause of rickets globally and is highly prevalent in developing countries including India. This study aimed to compare the efficacy of vitamin D and calcium together with calcium alone on growth parameters of children with vitamin D deficiency in community based setting.Methods: A randomized controlled trial was conducted in community based setting in Kanpur district. Multistage random sampling technique was used to select a total of 395 children between 2 years to 5 years from 5 villages of block Vidhunu. Of these, 138 children were randomized into two groups using balanced block randomization technique. Group 1 received vitamin D with calcium together and group 2 received calcium alone for a period of 12 months. Anthropometry, serum vitamin D, calcium, alkaline phosphatase levels were estimated at baseline and after 12 months. Data was analyzed using SPSS 20. Student’s t test was used to analyze the differences in growth and laboratory parameters in the two groups. Multiple linear regression analysis was used to assess the effect of various factors on the growth parameters.Results: Prevalence of vitamin D deficiency was 78.7%. Baseline characteristics of both groups were similar. After 12 months, group 1 demonstrated significantly greater improvement in weight SD score (21.4%) and height SD score (10.3%) and growth velocity (9.1 cm/year) compared to group 2 (14.3%, 7.8% and 6.9 cm/ year respectively). Also subjects in group 1 showed significantly greater improvement in serum levels of vitamin D, calcium and alkaline phosphatase than group 2.Conclusions: Vitamin D supplementation along with calcium improves the growth of children. Regular supplementation of all children with vitamin D can be considered as a policy for prevention of malnutrition.

Download Full-text

Relation of serum 25(OH) D with variables of thyroid and lipid profile in perimenopausal women

International Journal of Reproduction Contraception Obstetrics and Gynecology ◽

10.18203/2320-1770.ijrcog20170590 ◽

2017 ◽

Vol 6 (3) ◽

pp. 1087

Author(s):

Poonam Rani ◽

Seema Gupta ◽

Gaurav Gupta

Keyword(s):

Cardiovascular Disease ◽

Vitamin D ◽

Lipid Profile ◽

Vitamin D Deficiency ◽

Serum Levels ◽

The Body ◽

P Value ◽

Thyroid Disorder ◽

Vitamin D Levels ◽

Perimenopausal Women

Background: Deficiency of vitamin D is quite prevalent among elderly population or postmenopausal women worldwide and may affect various function of the body. The status of its deficiency with their relation with other variables are not well explored in perimenopausal women.Methods: 100 perimenopausal women from the department of obstetrics and gynaecology were selected without having known risk of thyroid disorder and cardiovascular disease. The age group criteria for these women were 40 to 50 years. Thyroid profile including TSH, T3, and T4 were estimated by using enzyme linked immunesorbent assay. Serum levels of 25(OH) D3 was estimated by using spectrophotometric method. Lipid profile including TC, TG and HDL-C were estimated CHOD-POD method, GPO-PAP method, and CHOD-POD/Phosphotungustate method. LDL-C was calculated by friedewald formula.Results: There 58 women were presented with insufficient amount of vitamin D. They were characterised with increased BMI, elevated thyrotropin alongwith lower concentrations of T3 and T4. Increased levels of TC, TG and LDL-cholesterol alongwith lower concentration of HDL-C were also observed in women with vitamin d deficiency. Women having vitamin D deficiency were presented with overweight (OR-18.0, p-value=<0.001) and dyslipidemia (OR-12.13, p-value≤0.001). Vitamin D was negatively correlated with variable i.e. BMI, TSH, TC, TG and LDL-C. This negative association was significant (<0.001) while HDL-C and T4 were positively correlated with vitamin D levels in this study population.Conclusions: Vitamin D deficiency frequently occurs in middle aged perimenopausal women. Negative correlation of it with BMI, TSH and lipid variables may suggest the development of cardiovascular disease and hypothyroidism in coming years. Vitamin D supplements or vitamin D containing diet and regular exposure to sun is highly recommended to perimenopausal women.

Download Full-text

Relationship between calcium metabolism and benign paroxysmal positional vertigo in north Sardinia population

Journal of Vestibular Research ◽

10.3233/ves-200025 ◽

2020 ◽

Vol 30 (6) ◽

pp. 375-382

Author(s):

Andrea Melis ◽

Davide Rizzo ◽

Roberto Gallus ◽

Maria Eleonora Leo ◽

Nicola Turra ◽

...

Keyword(s):

Vitamin D ◽

Vitamin D Deficiency ◽

Benign Paroxysmal Positional Vertigo ◽

High Accuracy ◽

T Score ◽

Positional Vertigo ◽

Vitamin D Levels ◽

The Impact ◽

Paroxysmal Positional Vertigo ◽

Group 1

BACKGROUND: Benign paroxysmal positional vertigo (BPPV) has a reported recurrence ranging from 26.8 to 50%. Osteoporosis and Vitamin D deficiency seems to have an impact on recurrence of BPPV. OBJECTIVE: to evaluate the impact of osteoporosis and Vitamin D deficiency on recurrence of BPPV. METHODS: 73 consecutive patients were divided in two groups according to the presence (group 1) or absence (group 0) of a recurrent episode. BMD, femoral and lumbar T-scores and Vitamin D levels were recorded. Statistical analysis was performed to investigate correlations. RESULTS: patients in group 1 had statistically significant lower values of both femoral (–1,62±1,06 vs. –0,53±1,51; p = 0,001), lumbar T-score (–2,10±1,19 vs –0, 53±1.51, p = 0.001) and Vitamin D (19.53±15.33). The values of femoral T-score and Vitamin D could be combined in a model able to properly classify 65.8% of the cases (p = 0.002) as isolated or recurrent BPPV, with high accuracy (AUC 0.710 [0.590 –0.830]). CONCLUSION: present data show a probable correlation between osteoporosis and Vitamin D with recurrent BPPV.

Download Full-text

25-OH-Vitamin-D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Is Associated With An Inferior Outcome Of Elderly DLBCL Patients Treated With Rituximab

Blood ◽

10.1182/blood.v122.21.1819.1819 ◽

2013 ◽

Vol 122 (21) ◽

pp. 1819-1819 ◽

Cited By ~ 1

Author(s):

Joerg Thomas Bittenbring ◽

Bettina Altmann ◽

Frank Neumann ◽

Marina Achenbach ◽

Joerg Reichrath ◽

...

Keyword(s):

Vitamin D ◽

Overall Survival ◽

Vitamin D Deficiency ◽

Multivariable Analysis ◽

Serum Levels ◽

Event Free Survival ◽

Free Survival ◽

Vitamin D Levels ◽

25 Oh Vitamin D ◽

The Impact

Abstract Background To investigate the impact and underlying mechanisms of vitamin-D-deficiency (VDD) on outcome of elderly (61 to 80 year-old) DLBCL patients. Methods Pretreatment 25-OH-vitamin-D serum levels from 359 patients treated in the prospective multicenter RICOVER-60 trial with 6 or 8 cycles of CHOP-14 with and without 8 cycles rituximab and 63 patients in the RICOVER-noRT study treated with 6xCHOP-14 + 8xR were determined determined by LIASION®, a commercially available chemoluminescent immunoassay. Results RICOVER-60 patients with VDD (defined as serum levels ≤8 ng/m l) and treated with rituximab had a 3-year event-free survival of 59% compared to 79% in patients with >8 ng/ml; 3-year overall survival was 70% and 82%, respectively. These differences were significant in a multivariable analysis adjusting for IPI risk factors with a hazard ratio of 2.1 [p=0.008] for event-free survival and 1.9 [p=0.040] for overall survival. In patients treated without rituximab 3-year EFS was not significantly different in patients with vitamin-D levels ≤8 and >8 ng/ml (HR 1.2; p=0.388). These results were confirmed in an independent validation set of 63 patients treated within the RICOVER-noRT study. Rituximab-mediated cellular toxicity (RMCC) against the CD20+ cell line Daudi as determined by LDH release assay increased significantly (p<0.005) in 5/5 vitamin-D-deficient individuals after vitamin-D substitution and normalization of their vitamin-D levels. Conclusions VDD is a significant risk factor for elderly DLBCL patients treated with rituximab. Our results show that VDD impairs RMCC and that RMCC can be improved by vitamin-D substitution. This together with the differential effect of VDD in patients treated with and without rituximab suggests that vitamin-D substitution might result in a better outcome of these patients when treated with CHOP plus rituximab. Supported by a grant from Deutsche Krebshilfe. Disclosures: No relevant conflicts of interest to declare.

Download Full-text